This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.30.21

Cannabis

• Barcelona cannabis clubs face closure in new legal setback (The Guardian)

• Black People in Colorado Are Still Arrested for Weed Twice as Much as Everyone Else (MERRY JANE)

• Epilepsy Patients Who Use ‘Artisanal CBD’ Have Higher Quality Of Life, Study Finds (Marijuana Moment)

• Is medical cannabis really a magic bullet? (The Guardian)

• New Study Finds California Cannabis Farms Irrigating with Groundwater May Affect Stream Flows (Sierra Sun Times)

• Ohio Lawmakers Officially File Marijuana Legalization Bill In Historic First For The State (Marijuana Moment)

• You Can Get a Free Eighth of Weed For Getting Vaccinated in SF (Broke Ass Stuart)

• California Senator Seeks Federal Clarification On Medical Marijuana Use In Hospitals (Marijuana Moment)

• How Mexico Has Legalized But Still Not Regulated Cannabis (Filter)

• Why cannabis is still a banned Olympics substance (BBC)

• Pop Star Lorde Smokes Weed Out of DIY Fennel Bulb Bong in New Music Video (MERRY JANE)

• Study: Marijuana Legalization Laws Don’t Undermine Tobacco Smoking Prevention Efforts (NORML)

LSD

• New study sheds light on how LSD’s entropic effects on the brain impact language production (PsyPost)

Magic Mushrooms

• Oregon State Board Says Psilocybin Is Effective At Treating Certain Mental Health Condition (Marijuana Moment)

• Psilocybin appears to alter how the brain integrates tactile sensory inputs (PsyPost)

• TheraPsil Launches New Campaign for Psilocybin Access (Truffle Report)

• Why Don’t Magic Mushroom Spores Contain Psilocybin? (Psychedelic Science Review)

• Psilocybe Cyanescens: A Mycologist’s Guide to Wavy Caps (DoubleBlind)

• Health Canada dragging feet on approving magic mushrooms for therapeutic use, patients and advocates say (CBC)

• More Details on the Psilocybin Mushroom Bluing Reaction (Psychedelic Science Review)

• Florida researchers work to understand power of psychedelics to treat mental illness (ABC7 Southwest Florida)

MDMA

• MDMA-assisted cognitive-behavioral therapy may help couples overcome PTSD (PsyPost)

• MDMA might be able to improve your already loving relationship, suggests Yale ethicist (KCRW)

• 'You Can Forgive Yourself:' Molly Helps Vets with PTSD, New Study Says (Military.com)

• How to reduce your risk of harm when taking MDMA and ecstasy (Metro)

• 2 Music Playlists For Therapeutic MDMA Sessions (Maps of the Mind)

DMT

• MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT (Psilocybin Alpha)

Ayahuasca

• Psychedelics, Religion, and the DEA’s Quest for Soul (Psychedelics Today)

• Drinking Psychedelic Brew Ayahuasca May Help Drug And Alcohol Addicts Quit (IFLScience)

• Joe Rogan And Comedian Ari Shaffir Discuss Tripping Balls On Ayahuasca (BroBible)

Iboga

• Gabon’s government is tripping for a psychedelic plant (Financial Times)

• Ibogaine: The Psychedelic Drug That Could Fight Addiction (Discover Magazine)

• MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research (Psilocybin Alpha)

Synthetic Cannabinoids

• Synthetic cannabis warning: Second death from 'dangerous' batch in Taranaki (New Zealand Herald)

Nitrous Oxide

• Mindful Use of Nitrous Oxide: How to be a Connoisseur of Getting High (Maps of the Mind)

Ketamine

• Tucson wrongful death lawsuit questions ketamine usage (ABC15 Arizona)

• Ketamine Therapy and Addiction Risk Management: Part III (Truffle Report)

• Understanding Where Ketamine Comes From (Healing Maps)

Miscellaneous

• House Rejects AOC Amendment To Promote Research Into Psychedelics’ Medical Benefits (Marijuana Moment)

• $40m psychedelic medicine institute launches in Melbourne (The Sydney Morning Herald)

• Psychedelic trips could soon be part of therapy — here’s what those sessions will look like (CNBC)

• How TikTok's Viral Psychedelic Water Might Affect Your Mood (Mashed)

• Philippines President Rodrigo Duterte Is About to Be Investigated for All the Drug Dealers He's Killed (MERRY JANE)

• Controversies Around California’s Psychedelic Decriminalization Law Senate Bill 519 (Chacruna)

• Judaism’s Psychedelic Renaissance (Tablet Magazine)

• Grandparents of Psychedelics Ann and Sasha Shulgin Honored by Friends and Fellow Researchers (Lucid News)

• Corrections to Misinformation Being Spread about MAPS and IPCI (Dr. Bronner's)

• “Undoing Drugs”—Maia Szalavitz’s Profound History of Harm Reduction (Filter)

• The Graeme Carl Scale: 5 Levels of a Psychedelic Experience (Maps of the Mind)

• Mestizo Identity and Decolonial Psychedelic Futures (Chacruna)

• Fireside Project for Psychedelic Peer Support: An Update (Truffle Report)

• Veteran Psychedelics Advocate/Attorney Launches New Venture Capital Firm (Forbes)

• Highlight on Life Clips, AI, and Speech Based Technology in Psychedelic Science (Dark Matters)

• The Lilly Psychonautic Centre – A Vision from the Future (Maps of the Mind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.5.21

Cannabis

• Virginia Lawmakers Vote to Legalize Marijuana in 2024 (TIME)

• Mexican Lawmakers To Vote On Marijuana Legalization Next Week (Marijuana Moment)

• Morocco Expected To Pass Cannabis Legalization Soon (High Times)

• New Mexico House Approves Marijuana Legalization Bill, With Senate Action Imminent (Marijuana Moment)

• Hawaii Marijuana Legalization Bill Heads To Senate Floor, Along With Separate Measure To Expand Decriminalization (Marijuana Moment)

• Third Minnesota House Committee Approves Marijuana Legalization Bill (Marijuana Moment)

• Tennessee Senators Approve Medical Marijuana Bill In Committee (Marijuana Moment)

• Alabama Senators Approve Marijuana Decriminalization Bill In Committee (Marijuana Moment)

• Washington, D.C. Could Allow Marijuana Sales Under Mayor’s New Bill And Democratic Control Of Congress (Marijuana Moment)

• Top Washington, D.C. Lawmaker Files Competing Legal Marijuana Bill Days After Mayor Unveils Her Plan (Marijuana Moment)

• Montana: Lawmakers Seek to Amend Voter-Approved Marijuana Legalization Law (NORML)

• Mississippi House Replaces Senate’s Alternate Medical Marijuana Program With What Voters Originally Approved (Marijuana Moment)

• 'I really love weed': Seth Rogen brings his cannabis company, Houseplant, to U.S. (NBC News)

• Study Indicates Most Patients Don’t Think Doctors Will Understand Cannabis (High Times)

• Pennsylvania Governor Grants 69 Marijuana Pardons As Lawmakers Move Bipartisan Legalization Bill (Marijuana Moment)

• Iowa Senators Approve Bill To Reduce Marijuana Penalties (Marijuana Moment)

• Review study: Cannabis and driving cognition (Marijuana Business Daily)

• Illinois city uses weed sales tax for reparations (Leafly)

• Marijuana Legalization Could Curb West Virginia’s Overdose Crisis, Governor Says (Filter)

• Decline In Banks Working With Marijuana Businesses Has ‘Leveled Off,’ New Federal Data Shows (Marijuana Moment)

• A New Observational Study Focusing On Cannabis For PTSD Treatment Has Been Approved (Forbes)

• Prisons should trial free cannabis, says UK's former chief drug adviser (The Guardian)

• Connecticut Polls Shows Majority Support For Marijuana Legalization And Expungements As Lawmakers Consider Reform (Marijuana Moment)

• Texas Voters’ Support For Legalizing Marijuana Is Increasing, New Poll Shows (Marijuana Moment)

LSD

• Benefits of microdosing LSD might be placebo effect, study finds (The Guardian)

• Can Psilocybin and LSD Relieve Existential Suffering? (Psychedelic Science Review)

• DEA: 'We've seen a very large increase in LSD' (KABB)

Magic Mushrooms

• Iowa Lawmakers Hold Historic Hearing On Psilocybin Decriminalization, But Do Not Advance Bill (Marijuana Moment)

• TheraPsil Launches Psilocybin Therapy Training Program (Truffle Report)

• Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin (BioSpace)

• PsyBio Therapeutics Initiates Pilot Scale Development of Proprietary Biosynthetic Psilocybin with Global Contract Research, Development and Manufacturing Organization (Psilocybin Alpha)

• MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin (Psilocybin Alpha)

• Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update (Psilocybin Alpha)

MDMA

• Promise and challenges for psilocybin and MDMA use in treatment (Peter Attia MD)

DMT

• A Beginner’s Guide to DMT Vape Pens (Truffle Report)

• Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK) (Psilocybin Alpha)

Ayahuasca

• Mail Order Ayahuasca Is Now A Thing (DoubleBlind)

• How Colombian Yagé Communities Confronted the COVID-19 Pandemic (Chacruna)

• Ayahuasca In the Fight Against Drug Addiction (CBD Testers)

5-MeO-DMT

• A Beginner’s Guide to Psychedelic Amphibians (Truffle Report)

Iboga

• MINDCURE Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research (PR Newswire)

• MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury (Psilocybin Alpha)

Synthetic Cannabinoids

• Drug Testing and Synthetic Cannabis in Prisons (Drug Science)

• Dangerous batch of synthetic cannabis may be behind Christchurch death (Stuff.co.nz)

Ketamine

• PharmaTher Expands to Neuromuscular Diseases with Exclusive License Agreement for Ketamine in the Treatment of Lou Gehrig’s Disease (GlobeNewswire)

• Awakn Announces Exclusive License Deal with the University of Exeter to Commercialise the ‘Ketamine in the Reduction of Alcoholic Relapse’ (KARE) Intervention Validated in a Phase II Clinical Trial (Psilocybin Alpha)

Miscellaneous

• Washington State Supreme Court finds state's felony drug possession law unconstitutional (Q13 Fox)

• U.S. Tells Mexico Drug War’s Failure Requires New Strategy (Bloomberg)

• Sewage Samples Reveal the Dutch, Australians Are Biggest Users of Synthetic Drugs (VICE)

• Canada’s Government Moves To End Mandatory Minimums For Drugs, But Voters Back Full Decriminalization (Marijuana Moment)

• Want To Take A Psychedelic Trip Without Drugs? There’s Now An App For That (Forbes)

• European companies set to dominate psychedelics market (Sifted)

• Online Psychedelic Community Options to Ride Out the Rest of Covid-19 (Psychedelics Today)

• Are Natural Psychedelics Or Synthetic Psychedelics Better For Your Body? (Healing Maps)

• CryptoPsychedelic Conferences Examine Links Between Psychedelics and Blockchain Technology (Lucid News)

• Psychedelics and Environmental Sustainability (Truffle Report)

• Growing popularity of therapeutic psychedelic experiences creates demand for underground guides (CBC)

• Investing In Psychedelics: Why Is It In Such High Demand These Days? (Healing Maps)

• Most People With Addiction Outgrow It Naturally. We Need to Hear Them. (Filter)

• Finding the Psychedelic Sweet Spot (Psychedelic Science Review)

• Does Animal Consciousness Expand From Psychedelics Too? (Reality Sandwich)

• Best Practices For Tripsitters (Maps of the Mind)

• What Effects Do Psychedelics Have on Social Perception? (Truffle Report)

• Christian Siriano’s Psychedelic Trip (The Cut)

• Red Light Holland’s iMicro Digital Care App Launches Virtual Telecounseling with a Membership Program Led by Certified Therapist and Microdosing Expert (Psilocybin Alpha)

• Growing interest in psychedelic treatments for mental illness, but expert warns more robust research needed (CBC)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 8.7.20

Cannabis

• Senator Files New Bill To Federally Legalize Marijuana And Regulate It Like Tobacco (Marijuana Moment)

• New study links marijuana to cardiovascular disease — but it's not all bad news (Salon)

• Louisiana Law Allowing Medical Marijuana For Any Debilitating Condition To Take Effect (Marijuana Moment)

• The pandemic is eating away at the illicit marijuana market (Politico)

• Weed Industry Workers Are Estimated to Outnumber Computer Programmers by End of 2020 (MERRY JANE)

• Grandmother Arrested For CBD At Disney World Sues Company With Powerful Legal Team (Marijuana Moment)

• VAPI anniversary: Killer chemicals still on the streets (Leafly)

• Colorado Youth Marijuana Use ‘Has Not Significantly Changed’ Since Legalization, State Data Shows (Marijuana Moment)

LSD

• Thought Loops: Trapped in Acid Chain Thinking (Reality Sandwich)

Magic Mushrooms

• Legal exemption for psilocybin therapy granted to 4 dying Canadians (Psillow)

• Beneficial Synergy: Teaming Psilocybin with Mindfulness Meditation (Psychedelic Science Review)

• Drug policy reform group urges Home Office to reschedule psilocybin (Health Europa)

• Usona Institute Publishes Breakthrough Development in Scalable Psilocybin Synthesis (Business Wire)

• Pioneering Psychedelic Researcher Once Again Paves the Way with Historic Psilocybin Study for End of Life Patients (Lucid News)

• Novamind Sponsors TheraPsil, an Advocate for the Compassionate Use of Psilocybin in Canada (Psilocybin Alpha)

• Mushroom Grow Kits: The 5 Best Mushroom Grow Kits for Growing Easily at Home (DoubleBlind)

MDMA

• Forget Plant-Based Medicine, MDMA is Now Made From Crude Oil (Psymposia)

• Hear The Music Used During Government Approved MDMA Psychotherapy Sessions (This Song Is Sick)

Ayahuasca

• Neuroimaging study suggests a single dose of ayahuasca produces lasting changes in two important brain networks (PsyPost)

• Ex-British army officer faces 13 years in Romanian jail over ayahuasca ceremony (The Guardian)

• Travel Insurance Will Never Cover This (So Don’t Even Ask) (Forbes)

• What is Changa? The Truth About Smokeable Ayahuasca (DoubleBlind)

Ketamine

• A Ketamine-Like Spray Is Approved to Treat Suicidal Behavior (The Cut)

• Ketamine’s promise as an antidepressant is being undermined by its lack of profit (Quartz)

• 'It was hell:' Ketamine shot sends Minneapolis man into intensive care, renews calls for investigation (Star Tribune)

Miscellaneous

• Psychedelics Decriminalization Initiative Officially Qualifies For D.C. Ballot (Marijuana Moment)

• How psychedelic drugs are used as a tool of state violence (Salon)

• Drugs, the Israelites and the Emergence of Patriarchy (Lucid News)

• Should Psychedelic Humanities Promote Psychedelic Humanism? (Chacruna)

• Mindleap Digital Health Platform Introduces New Psychedelic Programs For Mental Health (Green Market Report)

• Examining the Cognitive Neuroscience of Psychedelics (Psychedelic Science Review)

• Can Psychedelics Reveal Memories of Sexual Abuse? (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 6.19.20

Cannabis

• Louisiana Governor Signs Medical Marijuana Expansion Into Law (Marijuana Moment)

• Pennsylvania: Supreme Court Rules That Medical Cannabis Use Is Permissible While on Probation (NORML)

• New Jersey Assembly Approves Marijuana Decriminalization Bill Ahead Of Legalization Referendum (Marijuana Moment)

• Switzerland releases details on recreational marijuana experiment, but full legalization likely years away (Marijuana Business Daily)

• Nevada Pardons More Than 15,000 People With Marijuana Convictions Under Governor’s Resolution (Marijuana Moment)

• Nebraskans hustle to get medical legalization on ballot, with July 3 deadline (Leafly)

• Science Reveals The Cannabis Industry’s Greatest Lie: You’re Buying Weed Wrong (And So Is Everyone Else) (Forbes)

• Ohio Marijuana Activists Plan Supreme Court Appeal After Federal Judges Deny Electronic Signature Case (Marijuana Moment)

• Using cannabis during pregnancy could be bad news for your baby: new research (The Conversation)

• Library Of Congress Highlights Racist News Coverage Used To Justify Criminalizing Marijuana A Century Ago (Marijuana Moment)

• Patients Who Use Medical Cannabis Report Being Happier and Healthier Than Those Who Don’t (Grit Daily News)

• Fed report urges doctors to treat cannabis users as drug addicts (Leafly)

• Colorado Governor Could Issue Marijuana Pardons Under Social Equity Bill Lawmakers Sent To His Desk (Marijuana Moment)

• Cannabis Can Increase Intimacy and Reduce Anxiety During Sex, New Study Finds (MERRY JANE)

• CDC Flooded With Comments On Marijuana And Kratom As Alternative Painkillers Ahead Of Deadline (Marijuana Moment)

• These 3 Marijuana Nonprofits Are Offering Real Responses To The Pandemic And Racial Injustice (Green Entrepreneur)

• A Founder Looks at 50: The Important Role of Medical Experts in Support of Legalization (NORML)

• Lawmakers Push USDA To Let Hemp Farmers Access Coronavirus Relief Funds (Marijuana Moment)

• Why the Cannabis Sector May be Turning a New Leaf (Investopedia)

Magic Mushrooms

• Combining therapy with the psychedelic drug psilocybin results in large reductions in anxiety and depression (PsyPost)

• Colorado Activists Likely To Pursue 2022 Psilocybin Ballot Measure After Poll Shows Support (Marijuana Moment)

• Numinus receives Health Canada OK for mushrooms research (PressReader)

• Palliative Canadians endure punishing waits while Health Minister delays approval of Psilocybin mushrooms; TheraPsil expands effort to Ontario (Globe Newswire)

• A Deep Dive Inside Oregon’s Path to Legalizing Psilocybin Therapy (DoubleBlind)

• Life Sciences Firm Expands Collaboration Efforts with Major US University to Develop Psilocybin-Based Medicines (StreetWise Reports)

• New Wave Holdings Corp- Launching the first publicly-traded Psilocybin-growing operation (Value the Markets)

• Cannabis Company Eyes Medicinal Magic of Mushrooms (Real Money)

• Psilocybin to Treat Anxiety and Depression in Cancer Patients (Psychedelic Science Review)

• Cute as Children, but Not Handsome as Adults: María Sabina, Life Magazine, and Cold War Propaganda (Chacruna)

DMT

• MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1 Clinical Trial Collaboration (BioSpace)

• NeonMind Files Patent Application for Therapeutic Use of DMT (Yahoo! Finance)

Ayahuasca

• Is Ayahuasca Possibly Less than Five Hundred Years Old? (Chacruna)

Iboga

• Could ibogaine offer a revolutionary long-term solution to addiction? (Health Europa)

Synthetic Cannabinoids

• New K2 Compound in Canadian Heroin Supply Amid Surging Fatal ODs (Filter)

Nitrous Oxide

• Nitrous oxide use among young people is increasing in lockdown because it’s cheap and accessible (iNews)

Ketamine

• Why People are Using Ketamine Nasal Spray to Party (DoubleBlind)

• High Doses of Ketamine Can Temporarily Shut Down the Brain, Study Finds (MERRY JANE)

• Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals (Globe Newswire)

Miscellaneous

• UNC to Receive $26.9M from DARPA to Develop Psychiatric Medicines (Psychedelic Science Review)

• Microsoft reportedly tried to sell facial recognition tech to the DEA (Engadget)

• Mira X Acquisition Corp. Announces Proposed Qualifying Transaction with Field Trip Psychedelics Inc. (Yahoo! Finance)

• Fixing American policing also requires an end to the war on drugs (Baker Institute Blog)

• Champignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out (Globe Newswire)

• CFN Enterprises Launches Premier Psychedelics Stock Index Site: PsyIndex.com (Stockhouse)

• Beyond Stigma: How Researchers May Trigger Drug Users (Filter)

• Psychedelics Quickly Creating a Potential $100 Billion Market Opportunity (Baystreet)

• New Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory Board (PR Newswire)

• Seed crystal: on the contributions of Alexander Shulgin to the science of consciousness (Medium)

• Psychedelic Medical Start-Up AWAKN Life Sciences Enters the UK Market with Dr. Ben Sessa (Yahoo! Finance)

• Mota Ventures Appoints Roger C. Clinton as Member of Advisory Board to Verrian GmbH (MarketWatch)

• L’Chaim Psilocybin: How Psychedelics are Reigniting Judaism (DoubleBlind)

• Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp. (Yahoo! Finance)

• 2nd Gen Psychedelic Drugs For Depression Can Be Safer For Older Adults (Forbes)

• ‘Canada’s first psychedelic-enhanced psychotherapy centre’ changing how we treat depression (GlobalNews)

• Don’t Get Caught in a Trip Trap; Psychedelic Lessons for this Collective Moment (Lucid News)

• How psychedelic drugs could help our veterans (9News)

• Pure Extracts: The Second Wave of Psychedelic Operators (The Deep Dive)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.